Gastric hyperplastic polyps (GHPs) constitute 18 %-70 % of all gastric polyps. They are generally detected as innocuous incidental findings in 1.2 %-8 % of patients undergoing esophagogastroduodenoscopy; however, dysplasia or malignancy may be found within these GHPs in 2.1 %-8 % of patients [1-4]. Risk factors for the development of GHPs include Helicobacter pylori infection, previous gastric surgery (partial gastrectomy), autoimmune gastritis, liver cirrhosis, and noncirrhotic chronic liver disease causing portal hypertension [1-3, 5]. The etiopathogenesis of GHPs is unclear. The accepted hypothesis states that GHPs develop as the result of a hyperplastic mucosal healing regenerative response secondary to an inflammatory process [3]. Malignant transformation in GHPs has been reported in lesions > 10 mm, and therefore, endoscopic resection is recommended in these patients [2, 4, 6, 7]. However, results of endoscopic resection of GHPs are suboptimal and recurrences are frequent [8]. Large gastric hyperplastic polyps: to resect or not to resect, that is the question! Referring to Forté E et al. p. 444-453